Provided by Tiger Fintech (Singapore) Pte. Ltd.

MaxCyte Inc

2.57
-0.0400-1.53%
Post-market: 2.570.00000.00%16:33 EDT
Volume:545.52K
Turnover:1.41M
Market Cap:273.23M
PE:-6.56
High:2.68
Open:2.57
Low:2.53
Close:2.61
Loading ...

MaxCyte Announces Change in Major Holdings by BlackRock

TIPRANKS
·
16 Apr

Craig-Hallum Sticks to Its Buy Rating for MaxCyte (MXCT)

TIPRANKS
·
15 Apr

MaxCyte to Propose AIM Delisting to Shareholders

Dow Jones
·
15 Apr

BRIEF-Maxcyte Proposes Cancellation Of AIM Listing, Continues Nasdaq Listing

Reuters
·
15 Apr

MaxCyte Inc - Proposes Cancellation of Aim Listing, Continues Nasdaq Listing

THOMSON REUTERS
·
15 Apr

MaxCyte Announces Change in Voting Rights Structure

TIPRANKS
·
14 Apr

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025

GlobeNewswire
·
10 Apr

MaxCyte Announces Change in Major Holdings by BlackRock

TIPRANKS
·
08 Apr

With 66% institutional ownership, MaxCyte, Inc. (LON:MXCT) is a favorite amongst the big guns

Simply Wall St.
·
08 Apr

Down -30.2% in 4 Weeks, Here's Why MaxCyte (MXCT) Looks Ripe for a Turnaround

Zacks
·
07 Apr

MaxCyte (MXCT) Upgraded to Buy: Here's What You Should Know

Zacks
·
05 Apr

MaxCyte Announces CFO’s RSU Vesting and Share Sale

TIPRANKS
·
26 Mar

MaxCyte management to meet with BTIG

TIPRANKS
·
20 Mar

BlackRock Increases Stake in MaxCyte to 7.71%

TIPRANKS
·
19 Mar

BRIEF-Maxcyte Sees 2025 Core Revenue To Grow 8% To 15%

Reuters
·
12 Mar

MaxCyte Inc (MXCT) Q4 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges

GuruFocus.com
·
12 Mar

MaxCyte Inc - FY24 Net Loss $41.1 Mln VS Loss of $37.9 Mln in 2023

THOMSON REUTERS
·
12 Mar

MaxCyte Inc - Sees 2025 Core Revenue to Grow 8% to 15% Compared to 2024

THOMSON REUTERS
·
12 Mar

MaxCyte Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Mar

MaxCyte’s Strategic Expansion and Financial Resilience Drive Buy Rating

TIPRANKS
·
12 Mar